Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02111746 · ClinicalTrials.gov registry record · Phase 4
PAIN - Postoperative Analgesia INvestigation
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 350
- Enrollment target
NCT02111746: Completed Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
NCT02111746 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 350 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (32% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02111746, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 350 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy of the intraoperative injection of prolonged acting (liposomal) bupivacaine in postoperative pain control after truncal surgical incisions.
Primary Outcome
The Numeric Pain Scale (NPS) ranges from 0 ("no pain") to 10 ("worst possible pain").
Interventions
- DRUG Exparel
- DRUG Bupivacaine hydrochloride
- DRUG Patient Controlled Analgesia (PCA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2013-11-20 |
| Est. Completion | 2017-06-30 |
| Phase | Phase 4 |
What the finished NCT02111746 record still lists
NCT02111746 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (32% lower).
The record links to 0 conditions, and to 3 interventions - of which Exparel is the first listed.
NCT02111746 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02111746 about?
NCT02111746 is a clinical study titled "PAIN - Postoperative Analgesia INvestigation". The purpose of this study is to assess the efficacy of the intraoperative injection of prolonged acting (liposomal) bupivacaine in postoperative pain control after truncal surgical incisions.
What is the current status of trial NCT02111746?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 350 participants. The study started on 2013-11-20. Estimated completion is 2017-06-30.
What interventions are being tested in trial NCT02111746?
The interventions under investigation include: Exparel (DRUG), Bupivacaine hydrochloride (DRUG), Patient Controlled Analgesia (PCA) (DRUG).
Who is sponsoring clinical trial NCT02111746?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02111746's enrollment target sits among peer trials
350 231st of 2000 higher than 1,761 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI